» Articles » PMID: 17131391

Abeta(25-35) and Its C- And/or N-blocked Derivatives: Copper Driven Structural Features and Neurotoxicity

Overview
Journal J Neurosci Res
Specialty Neurology
Date 2006 Nov 30
PMID 17131391
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The toxic properties of beta-amyloid protein, Abeta(1-42), the major component of senile plaques in Alzheimer's disease, depend on nucleation-dependent oligomerization and aggregation. In addition, Abeta(1-42) toxicity is favored by the presence of trace metals, which affect the secondary structure of the peptide. A peptide comprising 11 residues within Abeta(1-42) [Abeta(25-35)] aggregates and retains the neurotoxic activity of Abeta(1-42). We have used both Abeta(25-35) and its C-amidated or N-acetylated/C-amidated derivatives to investigate the role of copper(II) in modulating the conformation and aggregation state as well as the neurotoxic properties of amyloid peptides. Electrospray ionization mass spectrometry (ESI-MS) and electron paramagnetic resonance (EPR) measurements were performed to verify the formation of copper(II)/Abeta(25-35) complexes and to determine the coordination mode, respectively. Abeta(25-35) and its derivatives were analyzed by circular dichroism spectroscopy to assess their secondary structure, subjected to thioflavine-T (Th-T) binding assay to reveal beta-sheet structured aggregates formation, and imaged by scanning force microscopy. Toxicity was assessed on mature cultures of rat cortical neurons. We found that beta-sheet-structured species of Abeta(25-35) were neurotoxic, whereas the random-coil-structured derivatives were devoid of effect. Interestingly, copper promoted the random-coil/beta-sheet transition of Abeta(25-35), with ensuing peptide toxicity, but it induced the toxicity of the N-acetylated/C-amidated derivative without affecting peptide folding. Moreover, copper did not influence either the folding or the activity of the C-amidated Abeta(25-35), suggesting that blockade of the C-terminus of Abeta peptides might be sufficient to prevent Abeta toxicity.

Citing Articles

A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action.

La Manna S, Di Natale C, Panzetta V, Leone M, Mercurio F, Cipollone I Inorg Chem. 2023; 63(1):564-575.

PMID: 38117944 PMC: 10777406. DOI: 10.1021/acs.inorgchem.3c03441.


Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide.

La Manna S, Leone M, Iacobucci I, Annuziata A, Di Natale C, Lagreca E Inorg Chem. 2022; 61(8):3540-3552.

PMID: 35171608 PMC: 9951207. DOI: 10.1021/acs.inorgchem.1c03540.


Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies.

Tencheva A, Liu R, Volkova T, Chayrov R, Mitrev Y, Sticha M Amino Acids. 2020; 52(11-12):1559-1580.

PMID: 33191465 DOI: 10.1007/s00726-020-02914-4.


Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes.

Florio D, Cuomo M, Iacobucci I, Ferraro G, Mansour A, Monti M Pharmaceuticals (Basel). 2020; 13(8).

PMID: 32751396 PMC: 7464691. DOI: 10.3390/ph13080171.


Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands.

Florio D, Iacobucci I, Ferraro G, Mansour A, Morelli G, Monti M Pharmaceuticals (Basel). 2019; 12(4).

PMID: 31614832 PMC: 6958441. DOI: 10.3390/ph12040154.